{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:57:35Z","timestamp":1787014655490,"version":"build-2736575974"},"reference-count":53,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T00:00:00Z","timestamp":1120694400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Ophthalmology"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective\u2002<\/jats:bold>\n                    To investigate the effect of 0.02% tacrolimus in aqueous suspension on tear production in dogs with keratoconjunctivitis sicca (KCS).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Animals studied\u2002<\/jats:bold>\n                    One hundred five dogs diagnosed with KCS [Schirmer tear test (STT) \u2264 10\u00a0mm\/min and clinical signs of dry eye]. Eyes with marginally decreased STT (11\u00a0\u2264\u00a015 mm\/min) and clinical signs of dry eye were also evaluated.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Procedure\u2002<\/jats:bold>\n                    The investigation was conducted in two parts: an initial efficacy study and a subsequent double blinded controlled study. In the efficacy study, the effect of topical tacrolimus (formerly FK\u2010506) on tear production in dogs with primary KCS was evaluated. Dogs were divided into four categories: 1) 59 eyes (38 dogs) na\u00efve to tear stimulation therapy with initial STT \u2264 10 mm\/min; 2) 28 eyes (21 dogs) na\u00efve to tear stimulation therapy with initial STT 11 \u2264 15 mm\/min; 3) 30 eyes (15 dogs) maintained successfully on CsA therapy; 4) 47 eyes (24 dogs) unresponsive to CsA therapy. STT and clinical signs were evaluated prior to and after 6 to 8 weeks of twice daily tacrolimus administration. Tacrolimus was substituted for CsA therapy in categories 3 and 4. The controlled study compared the effect of topical tacrolimus in aqueous suspension to administration of the aqueous carrier alone on tear production in 20 dogs with primary KCS.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    In the efficacy study, STT increased by 5 mm\/min in 84.7%, 25.0%, 26.7% and 51.1% of eyes in categories 1, 2, 3 and 4 respectively after tacrolimus administration. Eighty\u2010three percent of eyes with extremely low initial STT (\u2264 2 mm\/min), increased 5 mm\/min after tacrolimus. In the controlled study, STT increased by 5 mm\/min in 7\/10 dogs (14\/20 eyes) that received tacrolimus and in none of the 10 dogs that received aqueous carrier alone. Dogs receiving just the aqueous carrier were subsequently treated with tacrolimus, and STT increased 5 mm\/min in 9 dogs (18\/20 eyes) after administration.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions\u2002<\/jats:bold>\n                    Twice daily administration of 0.02% tacrolimus in aqueous suspension effectively increased tear production in dogs with KCS. Topical tacrolimus is a promising alternative to topical CsA for treatment of KCS and may be beneficial in patients with less than optimal response to topical CsA.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-5224.2005.00390.x","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T16:37:44Z","timestamp":1120754264000},"page":"225-232","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca"],"prefix":"10.1111","volume":"8","author":[{"given":"Andrew","family":"Berdoulay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Nadelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7,7]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"585","article-title":"Effect of atropine on tear formation in anesthetized dogs","volume":"175","author":"Ludders JW","year":"1979","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_3_2","first-page":"1006","article-title":"Decreased tear production associated with general anesthesia in the dog","volume":"174","author":"Vetsre WA","year":"1979","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_4_2","first-page":"1604","article-title":"Facial neuropathy in dogs and cats: 95 cases (1975\u201385)","volume":"191","author":"Kern TJ","year":"1987","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_5_2","first-page":"56","article-title":"Prolapse of the gland of the third eyelid in dogs. A retrospective study of 89 cases (1980\u201390)","volume":"29","author":"Morgan RV","year":"1993","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_6_6_2","first-page":"47","article-title":"Incidence of hypothyroidism in dogs affected by keratoconjunctivitis sicca (Abstract)","volume":"13","author":"Peruccio C","year":"1982","journal-title":"Annual Meeting of the American College of Veterinary Ophthalmologists"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2460\/javma.1992.200.12.1967","article-title":"Keratoconjunctivitis sicca and diabetes mellitus in a dog","volume":"200","author":"Barrera R","year":"1992","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_8_2","first-page":"43","article-title":"Ophthalmic complications following megavoltage irradiation of the nasal and paranasal cavities in dogs","volume":"190","author":"Roberts SM","year":"1987","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_9_2","first-page":"355","article-title":"Distemper\u2010associated keratoconjunctivitis sicca","volume":"21","author":"Martin CL","year":"1985","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_6_10_2","first-page":"309","volume-title":"Veterinary Ophthalmology","author":"Gelatt KN","year":"1991"},{"key":"e_1_2_6_11_2","first-page":"1566","article-title":"Keratoconjunctivitis sicca in dogs","volume":"158","author":"Aquirre GD","year":"1971","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_12_2","first-page":"112","article-title":"Keratoconjunctivitis sicca: histopathologic study of nictitating membrane and lacrimal glands from 28 dogs","volume":"45","author":"Kaswan RL","year":"1984","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_13_2","first-page":"376","article-title":"Keratoconjunctivitis sicca: immunologic evaluation of 62 cases","volume":"46","author":"Kaswan RL","year":"1985","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2002.63.688"},{"key":"e_1_2_6_15_2","first-page":"5","article-title":"Effects of ophthalmic cyclosporine on lacrimal gland pathology and function in dogs with keratoconjunctivitis sicca","volume":"5","author":"Bounous DI","year":"1996","journal-title":"Veterinary and Comparative Ophthalmology"},{"key":"e_1_2_6_16_2","first-page":"583","volume-title":"Veterinary Ophthalmology","author":"Moore CP","year":"1999"},{"key":"e_1_2_6_17_2","first-page":"230","volume-title":"Severin\u2019s: Veterinary Ophthalmology Notes","author":"Severin GA","year":"1996"},{"key":"e_1_2_6_18_2","first-page":"269","article-title":"Topical application of cyclosporine in the management of keratoconjunctivitis sicca in dogs","volume":"26","author":"Salisbury MA","year":"1990","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2460\/javma.1991.199.08.1043","article-title":"Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs","volume":"199","author":"Morgan RV","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2460\/javma.1991.199.08.1039","article-title":"Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs","volume":"199","author":"Olivero DK","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1989.01070020276038"},{"key":"e_1_2_6_22_2","first-page":"313","article-title":"Clinical use of pilocarpine for keratoconjunctivitis sicca in dogs and cats","volume":"151","author":"Rubin LF","year":"1967","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_23_2","first-page":"1","article-title":"Treatment of canine keratoconjunctivitis sicca by parotid duct transposition","volume":"6","author":"Gelatt KN","year":"1970","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.137.20.504"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-5616(90)50052-2"},{"key":"e_1_2_6_26_2","first-page":"653","article-title":"Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model","volume":"42","author":"Moore CP","year":"2001","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199811000-00014"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.40.1249"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.143.2.718","article-title":"The immunosuppressant FK506 selectively inhibits expression of early T\u2010cell activation genes","volume":"143","author":"Tocci MJ","year":"1989","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90111-J"},{"key":"e_1_2_6_31_2","first-page":"1265","article-title":"Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats","volume":"29","author":"Kawashima H","year":"1988","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"e_1_2_6_32_2","first-page":"901","article-title":"Use of topical FK506 in a corneal graft rejection model in Lewis rats","volume":"38","author":"Hikita N","year":"1997","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713689509033516"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1076\/ocii.6.2.101.4051"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-26727"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200105000-00020"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.1999.00834.x"},{"key":"e_1_2_6_38_2","first-page":"511","article-title":"Inconsistencies in the absorptive capacities of Schirmer tear test strips","volume":"188","author":"Hawkins EC","year":"1986","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_39_2","first-page":"196","article-title":"Temporal variation in tear production in normal beagle dogs as determined by Schirmer tear test","volume":"7","author":"Hakanson NW","year":"1997","journal-title":"Veterinary and Comparative Ophthalmology"},{"key":"e_1_2_6_40_2","unstructured":"ChambersL FischerC McCallaTet al.Topical tacrolimus in treatment of keratoconjunctivitis sicca: a multicenter preliminary clinical trial (poster).33rd Annual Meeting of the American College of Veterinary Ophthalmologists2002."},{"key":"e_1_2_6_41_2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","article-title":"Novel immunosuppressive agent, FK506","volume":"139","author":"Sawada S","year":"1987","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_42_2","first-page":"36","article-title":"Effect of FK506 on human mixed lymphocyte reaction in vitro","volume":"19","author":"Kino T","year":"1987","journal-title":"Transplantation Proceedings"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000211510"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199403000-00006"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-2867(97)80028-X"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00309052"},{"key":"e_1_2_6_47_2","first-page":"1059","article-title":"Blood levels of FK506 after intramuscular and intravenous administration in dogs","volume":"21","author":"Morimoto T","year":"1989","journal-title":"Transplantation Proceedings"},{"key":"e_1_2_6_48_2","first-page":"1399","article-title":"Optimal dose of FK506 in canine lung allotransplantation","volume":"24","author":"Fukuse T","year":"1992","journal-title":"Transplantation Proceedings"},{"key":"e_1_2_6_49_2","first-page":"98","article-title":"Pathological studies in canine and baboon allograft recipients immunosuppressed with FK506","volume":"19","author":"Thiru S","year":"1987","journal-title":"Transplantation Proceedings"},{"key":"e_1_2_6_50_2","first-page":"215","article-title":"Effect of FK506 in experimental transplantation","volume":"20","author":"Todo S","year":"1988","journal-title":"Transplantation Proceedings"},{"key":"e_1_2_6_51_2","first-page":"623","article-title":"Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs","volume":"41","author":"Misseghers BS","year":"2000","journal-title":"Canadian Veterinary Journal"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.2002.00299.x"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.5326\/0400029"},{"key":"e_1_2_6_54_2","first-page":"39","article-title":"An investigation of the safety and efficacy of topical ophthalmic application of tacrolimus in dogs (Abstract)","volume":"34","author":"Adkins EA","year":"2003","journal-title":"Annual Meeting of the American College of Veterinary Ophthalmologists"}],"container-title":["Veterinary Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-5224.2005.00390.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1463-5224.2005.00390.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T14:51:37Z","timestamp":1706367097000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1463-5224.2005.00390.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1111\/j.1463-5224.2005.00390.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-5224.2005.00390.x","archive":["Portico"],"relation":{},"ISSN":["1463-5216","1463-5224"],"issn-type":[{"value":"1463-5216","type":"print"},{"value":"1463-5224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"2005-07-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}